Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science
- PMID: 28480206
- PMCID: PMC5401661
- DOI: 10.21037/atm.2017.03.50
Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science
Conflict of interest statement
Conflicts of Interest: The Medical University of Vienna has claimed financial interest. Aposcience AG holds patents related to this work (EP20080450198 and EP20080450199). HJA is a shareholder of Aposcience AG. All other authors declare no potential conflicts of interest.
Comment on
-
Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration.Eur J Pharm Sci. 2017 Feb 15;98:86-95. doi: 10.1016/j.ejps.2016.09.017. Epub 2016 Sep 17. Eur J Pharm Sci. 2017. PMID: 27644894 Review.
References
-
- Lichtenauer M, Mildner M, Baumgartner A, et al. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 2011;106:645-55. 10.1007/s00395-011-0173-0 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources